Sedana Medical AB’s (publ) Annual Report describes important events and financial information for 2025, as well as the progress the company has made on its strategic priorities during the year.
“2025 was a successful year for Sedana Medical. For the first time as a listed company, we achieved profitability in our core business outside the United States, demonstrating the strength of our transformed operating model and establishing a stable, cash generating foundation for continued growth. At the same time, we made significant progress in reducing the risks related to US approval, including successful pivotal trials, FDA authorization of the Early Access Program, and positive regulatory interactions.", says Johannes Doll, President and CEO of Sedana Medical.
The Annual Report is available at www.sedanamedical.com.